« Previous
Next »
Fertility and Sterility
Volume 84, Issue 2
, Pages 313-318
, August 2005
Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists
References
- . GnRH antagonists (useful adjuncts for stimulation in women with poor ovarian reserve) . Fertil Steril . 2002;78:S1
- . Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF . J Assist Reprod Genet . 2003;20:455–460
- . Protocol of GnRH antagonist in poor responders in IVF-ET cycles . Ginekol Pol . 2003;74:943–948
- . Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders (results of a prospective randomized trial) . Hum Reprod . 2001;16:868–870
- Gonadotropin-releasing hormone antagonist protocol (a novel method of ovarian stimulation in poor responders) . Eur J Obstet Gynecol Reprod Biol . 2001;97:202–207
- Ovarian stimulation with hMG (results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin) . Hum Reprod . 2000;15:526–531
- . Gonadotropic control of ovarian follicular growth and development . Mol Cell Endocrinol . 2001;179:39–46
- . Effects of profound suppression of luteinizing hormone during ovarian stimulation on follicular activity, oocyte and embryo function in cycles stimulated with purified follicle stimulating hormone . Hum Reprod . 1998;13:1788–1792
- Suppression of LH during ovarian stimulation (analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH) . Hum Reprod . 2001;16:1636–1643
- . A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon) . Hum Reprod . 1998;13:3023–3031
- . Roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction . J Clin Endocrinol Metab . 2001;86:1437–1441
- . Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH) (a role for LH in the final stages of follicular maturation) . J Clin Endocrinol Metab . 1999;84:228–232
- . Role of periovulatory luteinizing hormone concentrations during assisted reproductive technology cycles stimulated exclusively with recombinant follicle-stimulating hormone . Fertil Steril . 2001;75:519–524
- . Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction . Hum Reprod . 2000;15:1003–1008
- LH serum levels during ovarian stimulation as predictors of ovarian response and assisted reproduction outcome in down-regulated women stimulated with recombinant FSH . Hum Reprod . 2003;18:2689–2697
- . Ovarian response of individuals to different doses of human menopausal gonadotropin . Fertil Steril . 1998;49:997–1001
- . Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles (a meta-analysis) . Fertil Steril . 1995;64:347–354
- . Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles (a meta-analysis) . Fertil Steril . 2000;73:338–343
- . Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles (a meta-analysis) . Fertil Steril . 2003;80:1086–1093
- Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix) . Hum Reprod . 1996;11:2114–2118
- Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation . Hum Reprod . 1994;9:788–791
- Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles (a prospective randomized study) . Hum Reprod . 2004;19:1979–1984
- Results of controlled ovarian stimulation for ART in poor responders according to the short protocol using different gonadotrophins combinations . Arch Gynecol Obstet . 2004;270:223–226
- . Recombinant luteinizing hormone in ovarian hyperstimulation after stimulation failure in normogonadotropic women . Gynecol Endocrinol . 1999;13:98–103
- . Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study . J Reprod Med . 2002;47:137–143
- Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome . Hum Reprod . 2000;15:2341–2346
- . Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotrophic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmatic sperm injection (a prospective randomized study) . Fertil Steril . 2001;76:543–549
-
.
Comparison between human menopausal gonadotropin and recombinant FSH for ovarian stimulation in patients undergoing in-vitro fertilization
.
Hum Reprod
. 2000;15:143
- . Recombinant follicle-stimulating hormone versus human menopausal gonadotropin in the late follicular phase during ovarian hyperstimulation for in vitro fertilization . Fertil Steril . 2002;78:1049–1054
PII: S0015-0282(05)00917-9
doi: 10.1016/j.fertnstert.2005.02.028
© 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 84, Issue 2
, Pages 313-318
, August 2005

